Uterine transposition in a patient with vulvar cancer

Objective: To report the first uterine transposition for fertility preservation in a patient with vulvar cancer.Case: A 26-year-old nulliparous patient with stage IIIB vulvar cancer, which was resected with adequate margins and bilateral inguinofemoral lymphadenectomy.Laparoscopic transposition of t...

Full description

Bibliographic Details
Main Authors: Joel Laufer, Santiago Scasso, Dana Kimelman, Clara Olmedo, Valeria Bentancor, Anne Soust, Gonzalo Sotero, Reitan Ribeiro
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Gynecologic Oncology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S235257892400016X
_version_ 1797234352237576192
author Joel Laufer
Santiago Scasso
Dana Kimelman
Clara Olmedo
Valeria Bentancor
Anne Soust
Gonzalo Sotero
Reitan Ribeiro
author_facet Joel Laufer
Santiago Scasso
Dana Kimelman
Clara Olmedo
Valeria Bentancor
Anne Soust
Gonzalo Sotero
Reitan Ribeiro
author_sort Joel Laufer
collection DOAJ
description Objective: To report the first uterine transposition for fertility preservation in a patient with vulvar cancer.Case: A 26-year-old nulliparous patient with stage IIIB vulvar cancer, which was resected with adequate margins and bilateral inguinofemoral lymphadenectomy.Laparoscopic transposition of the uterus to the upper abdomen, outside of the scope of radiation was performed to preserve fertility and ovarian function. After the end of radiotherapy, the uterus was repositioned into the pelvis.Main Outcome Measure: Uterine and ovarian function preservation. Result: The patient recovered her menstrual cycles spontaneously 1 month after the reimplantation and exhibited normal variation in ovarian hormones.Twelve months after the surgery, the uterus was normal and there was no sign of recurrent disease. Conclusion: Uterine transposition might represent a valid option for fertility preservation in women who require pelvic radiotherapy. However, studies that assess its viability, effectiveness, and safety are required.
first_indexed 2024-03-07T23:22:02Z
format Article
id doaj.art-9eded6b34c0842c883e6fc56b6fded75
institution Directory Open Access Journal
issn 2352-5789
language English
last_indexed 2024-04-24T16:30:42Z
publishDate 2024-04-01
publisher Elsevier
record_format Article
series Gynecologic Oncology Reports
spelling doaj.art-9eded6b34c0842c883e6fc56b6fded752024-03-30T04:39:21ZengElsevierGynecologic Oncology Reports2352-57892024-04-0152101337Uterine transposition in a patient with vulvar cancerJoel Laufer0Santiago Scasso1Dana Kimelman2Clara Olmedo3Valeria Bentancor4Anne Soust5Gonzalo Sotero6Reitan Ribeiro7Department of Gynecology C, Universidad de la República, Montevideo, Uruguay; Corresponding autor at: Bonpland 629, 11300 Montevideo, Uruguay.Department of Gynecology, British Hospital, Montevideo, UruguayOncofertility Program. Hospital Pereira Rossell, ASSE, Montevideo, UruguayDepartment of Gynecology C, Universidad de la República, Montevideo, UruguayDepartment of Gynecology C, Universidad de la República, Montevideo, UruguayDepartment of Gynecology C, Universidad de la República, Montevideo, UruguayDepartment of Gynecology C, Universidad de la República, Montevideo, UruguayDepartment of Surgical Oncology, Erasto Gaertner Hospital, Curitiba, BrazilObjective: To report the first uterine transposition for fertility preservation in a patient with vulvar cancer.Case: A 26-year-old nulliparous patient with stage IIIB vulvar cancer, which was resected with adequate margins and bilateral inguinofemoral lymphadenectomy.Laparoscopic transposition of the uterus to the upper abdomen, outside of the scope of radiation was performed to preserve fertility and ovarian function. After the end of radiotherapy, the uterus was repositioned into the pelvis.Main Outcome Measure: Uterine and ovarian function preservation. Result: The patient recovered her menstrual cycles spontaneously 1 month after the reimplantation and exhibited normal variation in ovarian hormones.Twelve months after the surgery, the uterus was normal and there was no sign of recurrent disease. Conclusion: Uterine transposition might represent a valid option for fertility preservation in women who require pelvic radiotherapy. However, studies that assess its viability, effectiveness, and safety are required.http://www.sciencedirect.com/science/article/pii/S235257892400016XUterine transpositionVulvar cancerPelvic radiotherapyFertility preservation
spellingShingle Joel Laufer
Santiago Scasso
Dana Kimelman
Clara Olmedo
Valeria Bentancor
Anne Soust
Gonzalo Sotero
Reitan Ribeiro
Uterine transposition in a patient with vulvar cancer
Gynecologic Oncology Reports
Uterine transposition
Vulvar cancer
Pelvic radiotherapy
Fertility preservation
title Uterine transposition in a patient with vulvar cancer
title_full Uterine transposition in a patient with vulvar cancer
title_fullStr Uterine transposition in a patient with vulvar cancer
title_full_unstemmed Uterine transposition in a patient with vulvar cancer
title_short Uterine transposition in a patient with vulvar cancer
title_sort uterine transposition in a patient with vulvar cancer
topic Uterine transposition
Vulvar cancer
Pelvic radiotherapy
Fertility preservation
url http://www.sciencedirect.com/science/article/pii/S235257892400016X
work_keys_str_mv AT joellaufer uterinetranspositioninapatientwithvulvarcancer
AT santiagoscasso uterinetranspositioninapatientwithvulvarcancer
AT danakimelman uterinetranspositioninapatientwithvulvarcancer
AT claraolmedo uterinetranspositioninapatientwithvulvarcancer
AT valeriabentancor uterinetranspositioninapatientwithvulvarcancer
AT annesoust uterinetranspositioninapatientwithvulvarcancer
AT gonzalosotero uterinetranspositioninapatientwithvulvarcancer
AT reitanribeiro uterinetranspositioninapatientwithvulvarcancer